In The Fight Against Cancer, It's A Tumor's Worst Enemy

BOCA RATON, Fla., Dec. 16, 2015 /PRNewswire-USNewswire/ -- Offering new hope to patients with tumors that were once considered untreatable with surgery or conventional radiation therapy, the Eugene M. & Christine E. Lynn Cancer Institute (LCI) at Boca Raton Regional Hospital is now utilizing the Accuray CyberKnife^® M6™ System with InCise2 technology. Boca Regional now joins the renowned Hillman Cancer Center at the University of Pittsburgh Medical Center as the only two oncology programs in the country to offer this specific therapy.

Unlike other forms of radiosurgery, this latest generation of the CyberKnife offers an unprecedented ability to precisely target tumors while sparing damage to surrounding healthy tissue.

What makes this version of the CyberKnife so unique – and so effective – is its ability to continuously track and attack the tumor as it shifts during therapy due to patient movement or respiration.

"The InCise2 technology uses what is called a Multileaf Collimator and 3D robotic navigation which allow us to sculpt and re-sculpt the field of radiation we are delivering throughout the procedure and automatically correct for any tumor movement," said Tim Williams, MD, Medical Director of Radiation Oncology at LCI. "With other systems, when the tumor moves you have to stop the radiation, wait for the mass to return to its original position, and then restart the therapy."

This combination of exquisite accuracy and the ability to adjust to tumor motion allows the radiation therapy team to carry out the procedure with the highest level of precision. The System's advanced maneuverability also offers complete access and coverage for any tumor size or shape, even in anatomically difficult areas. In turn, these capabilities enable the delivery of higher radiation doses resulting in a reduced number of total treatments and a reduction in the individual treatment time from 60 minutes or more with prior versions of the CyberKnife to less than 30 with the M6 InCise2 technology.

"This generation of Cyberknife is truly the state-of-the-art in radiation therapy," commented Dr. Williams. "In addition to its tremendous efficacy, the procedure requires no anesthesia, no recovery time, no overnight hospital stay and no restrictive positioning devices that are used in other technologies. As you can imagine, these are all tremendous patient and family satisfiers."

Dr. Williams noted that the CyberKnife at LCI is presently being used to treat malignant and non-malignant tumors of the prostate, lung, brain, spine, liver, pancreas, kidney, bone and eye.

About Boca Raton Regional Hospital – Advancing the Boundaries of Medicine.
Boca Raton Regional Hospital is an advanced, tertiary medical center (BRRH.com) with 400 beds and more than 800 primary and specialty physicians on staff. The Hospital is a recognized leader in oncology, cardiovascular disease and surgery, minimally invasive surgery, orthopedics, women's health, emergency medicine and the neurosciences, all of which offer state-of-the-art diagnostic and imaging capabilities. The Lynn Cancer Institute is accredited by the American College of Surgeons Commission on Cancer (CoC).

Media Contact:
Thomas Chakurda, 561.955.3586
Vice President, Marketing
[email protected]  

SOURCE Boca Raton Regional Hospital

Related Links

http://www.brrh.com